Puma Biotechnology, Inc. (NASDAQ:PBYI)
| Market Cap | $364.47M+41.6% |
| Revenue (ttm) | $231.82M+9.4% |
| Net Income | $23.83M-35.6% |
| EPS | $0.46-38.3% |
| Shares Out | 51.70M |
| PE Ratio | 14.80 |
| Forward PE | 29.38 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 861,208 |
| Open | $7.05 |
| Previous Close | $7.12 |
| Day's Range | $6.91 - $7.22 |
| 52-Week Range | $4.84 - $11.50 |
| Beta | 1.21 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Feb 25, 2027 |
About PBYI
Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Feb 25, 2027Earnings report
$PBYI stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of PBYI by members of U.S. Congress
| Donna ShalalaHouse | Sale$1.00K – $15.00K | May 15, 2019 |
| Donna ShalalaHouse | Purchase$1.00K – $15.00K | Jan 23, 2019 |
Recently reported changes in PBYI holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PBYI's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PBYI Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PBYI Revenue by Segment
| Commercialization | $9.79M | 62.53% |
| Stock-based compensation | $5.87M | 37.47% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PBYI patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PBYI from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PBYI
| AVUVAvantis U.S. Small Cap Value ETF | $18.37M |
| VTIVanguard Morningstar Total Stock Market ETF | $11.05M |
| IWMiShares Russell 2000 ETF | $8.44M |
| VXFVanguard Extended Market ETF | $4.76M |
| DFATDimensional - US Targeted Value ETF | $2.93M |
| VTWOVanguard Russell 2000 ETF | $2.72M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from PBYI’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
+0.0 since Sep 17Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| FDM | First Trust Dow Jones Select MicroCap Index Fund | 0.50% |
| BRSV | EA Series Trust - EA Bridgeway Select Small-Cap Value ETF | 0.45% |
| AESL | Harbor AlphaEdge Small Cap Value ETF | 0.42% |
| ROSC | Hartford Multifactor Small Cap ETF | 0.41% |
| LITL | Simplify Piper Sandler US Small-Cap PLUS Income ETF | 0.41% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.37% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.27% |
| AESG | Harbor AlphaEdge Small Cap Growth ETF | 0.26% |
| AESB | Harbor AlphaEdge Small Cap Core ETF | 0.23% |
| BUSM | EA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | 0.21% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.18% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.09% |
Weight is the stock’s share of each fund’s holdings.
